US2007198081A1PendingUtilityA1
Poly(butylmethacrylate) and rapamycin coated stent
Est. expirySep 28, 2020(expired)· nominal 20-yr term from priority
A61L 2300/416A61F 2/86A61L 31/16A61L 31/088A61L 27/56A61L 2300/602A61L 2300/606A61F 2/82A61F 2310/0097A61L 31/10A61F 2250/0067A61L 2420/08A61L 27/34A61L 27/306
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A drug eluting stent is disclosed. The stent includes a stent base; a basecoat formulation comprising Sirolimus in a polymer coating, wherein the polymer coating contains ethylene-co-vinyl acetate and poly-n-butyl methacrylate; and a topcoat disposed on the basecoat formulation.
Claims
exact text as granted — not AI-modified1 .- 21 . (canceled)
22 . A Sirolimus-eluting coronary stent comprising:
a stent base; a basecoat formulation comprising Sirolimus in a polymer coating, wherein the polymer coating contains ethylene-co-vinyl acetate and poly-n-butyl methacrylate; and a topcoat disposed on the basecoat formulation.
23 . A stent comprising:
a substrate; a Sirolimus layer comprising Sirolimus and poly-n-butyl methacrylate, the Sirolimus layer supported by the substrate; and a barrier layer over at least a portion of the Sirolimus layer.Join the waitlist — get patent alerts
Track US2007198081A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.